Parthenon LLC Bristol Myers Squibb CO Transaction History

Parthenon LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $371,365 - $412,343	-5,829 Reduced 59.17%	4,023 $257,000
Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $110 - $65,237	-849 Reduced 7.93%	9,852 $700,000
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $34,081 - $39,922	-576 Reduced 5.11%	10,701 $633,000
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $35,660 - $38,833	576 Added 5.38%	11,277 $754,000
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $17,322 - $19,629	300 Added 2.88%	10,701 $664,000
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $49,210 - $64,190	1,000 Added 10.64%	10,401 $668,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $68,380 - $77,127	-1,239 Reduced 11.64%	9,401 $584,000
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $587,647 - $678,193	10,640	10,640 $678,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Parthenon LLC, based on Form 13F filings with the SEC.

Stay updated on Parthenon LLC with notifications on news.